Download PDF
Neuropediatrics 2015; 46(02): 088-097
DOI: 10.1055/s-0035-1549098
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Applications of Optical Coherence Tomography in Pediatric Clinical Neuroscience

Robert A. Avery
1   The Gilbert Family Neurofibromatosis Institute, Children's National Health System, Washington, District of Columbia, United States
2   Department of Neurology, Children's National Health System, Washington, District of Columbia, United States
3   Department of Ophthalmology, Children's National Health System, Washington, District of Columbia, United States
4   Department of Pediatrics, Children's National Health System, Washington, District of Columbia, United States
5   Center for Neuroscience and Behavior, Children's National Health System, Washington, District of Columbia, United States
,
Raneem D. Rajjoub
6   George Washington University School of Medicine, Washington, District of Columbia, United States
,
Carmelina Trimboli-Heidler
1   The Gilbert Family Neurofibromatosis Institute, Children's National Health System, Washington, District of Columbia, United States
,
Amy T. Waldman
7   Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
› Author Affiliations
Further Information

Publication History

29 December 2014

26 February 2015

Publication Date:
24 March 2015 (online)

    Permissions and Reprints

Abstract

For nearly two centuries, the ophthalmoscope has permitted examination of the retina and optic nerve—the only axons directly visualized by the physician. The retinal ganglion cells project their axons, which travel along the innermost retina to form the optic nerve, marking the beginning of the anterior visual pathway. Both the structure and function of the visual pathway are essential components of the neurologic examination as it can be involved in numerous acquired, congenital and genetic central nervous system conditions. The development of optical coherence tomography now permits the pediatric neuroscientist to visualize and quantify the optic nerve and retinal layers with unprecedented resolution. As optical coherence tomography becomes more accessible and integrated into research and clinical care, the pediatric neuroscientist may have the opportunity to utilize and/or interpret results from this device. This review describes the basic technical features of optical coherence tomography and highlights its potential clinical and research applications in pediatric clinical neuroscience including optic nerve swelling, optic neuritis, tumors of the visual pathway, vigabatrin toxicity, nystagmus, and neurodegenerative conditions.

Keywords

optical coherence tomography - optic neuritis - papilledema - optic pathway gliomas
 

  • References

  • 1 Huang D, Swanson EA, Lin CP , et al. Optical coherence tomography. Science 1991; 254 (5035) 1178-1181
    CrossrefPubMedGoogle Scholar
  • 2 Schuman JS, Hee MR, Puliafito CA , et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol 1995; 113 (5) 586-596
    CrossrefPubMedGoogle Scholar
  • 3 Garway-Heath DF, Poinoosawmy D, Fitzke FW, Hitchings RA. Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology 2000; 107 (10) 1809-1815
    CrossrefPubMedGoogle Scholar
  • 4 Yanni SE, Wang J, Cheng CS , et al. Normative reference ranges for the retinal nerve fiber layer, macula, and retinal layer thicknesses in children. Am J Ophthalmol 2013; 155 (2) 354-360
    CrossrefPubMedGoogle Scholar
  • 5 Turk A, Ceylan OM, Arici C , et al. Evaluation of the nerve fiber layer and macula in the eyes of healthy children using spectral-domain optical coherence tomography. Am J Ophthalmol 2012; 153 (3) 552-559
    CrossrefPubMedGoogle Scholar
  • 6 Avery RA, Cnaan A, Schuman JS , et al. Reproducibility of circumpapillary retinal nerve fiber layer measurements using handheld optical coherence tomography in sedated children. Am J Ophthalmol 2014; 158 (4) 780-787
    CrossrefPubMedGoogle Scholar
  • 7 Avery RA, Cnaan A, Schuman JS , et al. Intra- and inter-visit reproducibility of ganglion cell-inner plexiform layer measurements using handheld optical coherence tomography in children with optic pathway gliomas. Am J Ophthalmol 2014; 158 (5) 916-923
    CrossrefPubMedGoogle Scholar
  • 8 Syc SB, Warner CV, Hiremath GS , et al. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler 2010; 16 (7) 829-839
    CrossrefPubMedGoogle Scholar
  • 9 Altemir I, Pueyo V, Elía N, Polo V, Larrosa JM, Oros D. Reproducibility of optical coherence tomography measurements in children. Am J Ophthalmol 2013; 155 (1) 171-176
    CrossrefPubMedGoogle Scholar
  • 10 Langenegger SJ, Funk J, Töteberg-Harms M. Reproducibility of retinal nerve fiber layer thickness measurements using the eye tracker and the retest function of Spectralis SD-OCT in glaucomatous and healthy control eyes. Invest Ophthalmol Vis Sci 2011; 52 (6) 3338-3344
    CrossrefPubMedGoogle Scholar
  • 11 Serbecic N, Beutelspacher SC, Aboul-Enein FC, Kircher K, Reitner A, Schmidt-Erfurth U. Reproducibility of high-resolution optical coherence tomography measurements of the nerve fibre layer with the new Heidelberg Spectralis optical coherence tomography. Br J Ophthalmol 2011; 95 (6) 804-810
    CrossrefPubMedGoogle Scholar
  • 12 Gu S, Glaug N, Cnaan A, Packer RJ, Avery RA. Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas. Invest Ophthalmol Vis Sci 2014; 55 (3) 1402-1408
    CrossrefPubMedGoogle Scholar
  • 13 Walter SD, Ishikawa H, Galetta KM , et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 2012; 119 (6) 1250-1257
    CrossrefPubMedGoogle Scholar
  • 14 Kardon RH. Role of the macular optical coherence tomography scan in neuro-ophthalmology. J Neuroophthalmol 2011; 31 (4) 353-361
    CrossrefPubMedGoogle Scholar
  • 15 Barboni P, Savini G, Cascavilla ML , et al. Early macular retinal ganglion cell loss in dominant optic atrophy: genotype-phenotype correlation. Am J Ophthalmol 2014; 158 (3) 628-36
    CrossrefPubMedGoogle Scholar
  • 16 Aggarwal D, Tan O, Huang D, Sadun AA. Patterns of ganglion cell complex and nerve fiber layer loss in nonarteritic ischemic optic neuropathy by Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2012; 53 (8) 4539-4545
    CrossrefPubMedGoogle Scholar
  • 17 Lee H, Sheth V, Bibi M , et al. Potential of handheld optical coherence tomography to determine cause of infantile nystagmus in children by using foveal morphology. Ophthalmology 2013; 120 (12) 2714-2724
    CrossrefPubMedGoogle Scholar
  • 18 Rajjoub RD, Trimboli-Heidler C, Packer RJ, Avery RA. Reproducibility of retinal nerve fiber layer thickness measures using eye tracking in children with nonglaucomatous optic neuropathy. Am J Ophthalmol 2015; 159 (1) 71-77
    CrossrefPubMedGoogle Scholar
  • 19 Avery RA, Hwang EI, Ishikawa H , et al. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. JAMA Ophthalmol 2014; 132 (3) 265-271
    CrossrefPubMedGoogle Scholar
  • 20 Moreno TA, O'Connell RV, Chiu SJ , et al. Choroid development and feasibility of choroidal imaging in the preterm and term infants utilizing SD-OCT. Invest Ophthalmol Vis Sci 2013; 54 (6) 4140-4147
    CrossrefPubMedGoogle Scholar
  • 21 Cabrera MT, O'Connell RV, Toth CA , et al. Macular findings in healthy full-term Hispanic newborns observed by hand-held spectral-domain optical coherence tomography. Ophthalmic Surg Lasers Imaging Retina 2013; 44 (5) 448-454
    CrossrefPubMedGoogle Scholar
  • 22 Cabrera MT, Maldonado RS, Toth CA , et al. Subfoveal fluid in healthy full-term newborns observed by handheld spectral-domain optical coherence tomography. Am J Ophthalmol 2012; 153 (1) 167-75
    CrossrefPubMedGoogle Scholar
  • 23 Maldonado RS, O'Connell RV, Sarin N , et al. Dynamics of human foveal development after premature birth. Ophthalmology 2011; 118 (12) 2315-2325
    CrossrefPubMedGoogle Scholar
  • 24 Maldonado RS, Izatt JA, Sarin N , et al. Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. Invest Ophthalmol Vis Sci 2010; 51 (5) 2678-2685
    CrossrefPubMedGoogle Scholar
  • 25 Chavala SH, Farsiu S, Maldonado R, Wallace DK, Freedman SF, Toth CA. Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging. Ophthalmology 2009; 116 (12) 2448-2456
    CrossrefPubMedGoogle Scholar
  • 26 Gerth C, Zawadzki RJ, Héon E, Werner JS. High-resolution retinal imaging in young children using a handheld scanner and Fourier-domain optical coherence tomography. J AAPOS 2009; 13 (1) 72-74
    CrossrefPubMedGoogle Scholar
  • 27 Gerth C, Zawadzki RJ, Werner JS, Héon E. Retinal morphology in patients with BBS1 and BBS10 related Bardet-Biedl Syndrome evaluated by Fourier-domain optical coherence tomography. Vision Res 2008; 48 (3) 392-399
    CrossrefPubMedGoogle Scholar
  • 28 Muni RH, Kohly RP, Charonis AC, Lee TC. Retinoschisis detected with handheld spectral-domain optical coherence tomography in neonates with advanced retinopathy of prematurity. Arch Ophthalmol 2010; 128 (1) 57-62
    CrossrefPubMedGoogle Scholar
  • 29 Muni RH, Kohly RP, Sohn EH, Lee TC. Hand-held spectral domain optical coherence tomography finding in shaken-baby syndrome. Retina 2010; 30 (4, Suppl): S45-S50
    CrossrefPubMedGoogle Scholar
  • 30 Lee H, Proudlock F, Gottlob I. Is handheld optical coherence tomography reliable in infants and young children with and without nystagmus?. Invest Ophthalmol Vis Sci 2013; 54 (13) 8152-8159
    CrossrefPubMedGoogle Scholar
  • 31 Fard MA, Fakhree S, Abdi P, Hassanpoor N, Subramanian PS. Quantification of peripapillary total retinal volume in pseudopapilledema and mild papilledema using spectral-domain optical coherence tomography. Am J Ophthalmol 2014; 158 (1) 136-143
    CrossrefPubMedGoogle Scholar
  • 32 Auinger P, Durbin M, Feldon S , et al; OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci 2014; 55 (12) 8180-8188
    CrossrefPubMedGoogle Scholar
  • 33 Wang JK, Kardon RH, Kupersmith MJ, Garvin MK. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2012; 53 (7) 4069-4075
    CrossrefPubMedGoogle Scholar
  • 34 Sibony P, Kupersmith MJ, Rohlf FJ. Shape analysis of the peripapillary RPE layer in papilledema and ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2011; 52 (11) 7987-7995
    CrossrefPubMedGoogle Scholar
  • 35 Kupersmith MJ, Sibony P, Mandel G, Durbin M, Kardon RH. Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema. Invest Ophthalmol Vis Sci 2011; 52 (9) 6558-6564
    CrossrefPubMedGoogle Scholar
  • 36 Kulkarni KM, Pasol J, Rosa PR, Lam BL. Differentiating mild papilledema and buried optic nerve head drusen using spectral domain optical coherence tomography. Ophthalmology 2014; 121 (4) 959-963
    CrossrefPubMedGoogle Scholar
  • 37 Lee KM, Woo SJ, Hwang JM. Differentiation of optic nerve head drusen and optic disc edema with spectral-domain optical coherence tomography. Ophthalmology 2011; 118 (5) 971-977
    CrossrefPubMedGoogle Scholar
  • 38 Wall M, McDermott MP, Kieburtz KD , et al; NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA 2014; 311 (16) 1641-1651
    CrossrefPubMedGoogle Scholar
  • 39 Merchant KY, Su D, Park SC , et al. Enhanced depth imaging optical coherence tomography of optic nerve head drusen. Ophthalmology 2013; 120 (7) 1409-1414
    CrossrefPubMedGoogle Scholar
  • 40 Moss HE, Treadwell G, Wanek J, DeLeon S, Shahidi M. Retinal vessel diameter assessment in papilledema by semi-automated analysis of SLO images: feasibility and reliability. Invest Ophthalmol Vis Sci 2014; 55 (4) 2049-2054
    CrossrefPubMedGoogle Scholar
  • 41 Auinger P, Durbin M, Feldon S , et al; OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci 2014; 55 (12) 8173-8179
    CrossrefPubMedGoogle Scholar
  • 42 Costello F, Coupland S, Hodge W , et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59 (6) 963-969
    CrossrefPubMedGoogle Scholar
  • 43 Petzold A, de Boer JF, Schippling S , et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 2010; 9 (9) 921-932
    CrossrefPubMedGoogle Scholar
  • 44 Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 2009; 132 (Pt 3): 628-634
    CrossrefPubMedGoogle Scholar
  • 45 Gordon-Lipkin E, Chodkowski B, Reich DS , et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007; 69 (16) 1603-1609
    CrossrefPubMedGoogle Scholar
  • 46 Yeh EA, Weinstock-Guttman B, Lincoff N , et al. Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset. Mult Scler 2009; 15 (7) 802-810
    CrossrefPubMedGoogle Scholar
  • 47 Waldman AT, Hiremath G, Avery RA , et al. Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis. Mult Scler Relat Disord 2013; 3 (3) 326-334
    PubMedGoogle Scholar
  • 48 Yilmaz Ü, Gücüyener K, Erin DM , et al. Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis. J Child Neurol 2012; 27 (12) 1517-1523
    CrossrefPubMedGoogle Scholar
  • 49 Talman LS, Bisker ER, Sackel DJ , et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010; 67 (6) 749-760
    PubMedGoogle Scholar
  • 50 Huhn K, Lämmer R, Oberwahrenbrock T , et al. Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage. Eur J Neurol 2015; 22 (1) 86-92
    CrossrefPubMedGoogle Scholar
  • 51 Saidha S, Syc SB, Durbin MK , et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 2011; 17 (12) 1449-1463
    CrossrefPubMedGoogle Scholar
  • 52 Garcia-Martin E, Polo V, Larrosa JM , et al. Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography. Ophthalmology 2014; 121 (2) 573-579
    CrossrefPubMedGoogle Scholar
  • 53 Yeh EA, Marrie RA, Reginald YA , et al; Canadian Pediatric Demyelinating Disease Network. Functional-structural correlations in the afferent visual pathway in pediatric demyelination. Neurology 2014; 83 (23) 2147-2152
    CrossrefPubMedGoogle Scholar
  • 54 Saidha S, Sotirchos ES, Oh J , et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 2013; 70 (1) 34-43
    CrossrefPubMedGoogle Scholar
  • 55 Bennett J, de Seze J, Lana-Peixoto M , et al; with the GJCF-ICC&BR. Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Mult Scler 2015; ; In press
    PubMedGoogle Scholar
  • 56 Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuroophthalmol 2011; 31 (3) 269-278
    CrossrefPubMedGoogle Scholar
  • 57 Costello F, Van Stavern GP. Should optical coherence tomography be used to manage patients with multiple sclerosis?. J Neuroophthalmol 2012; 32 (4) 363-371
    CrossrefPubMedGoogle Scholar
  • 58 Saidha S, Syc SB, Ibrahim MA , et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134 (Pt 2): 518-533
    CrossrefPubMedGoogle Scholar
  • 59 Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 2012; 135 (Pt 6) 1786-1793
    CrossrefPubMedGoogle Scholar
  • 60 Saidha S, Sotirchos ES, Ibrahim MA , et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 2012; 11 (11) 963-972
    CrossrefPubMedGoogle Scholar
  • 61 Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009; 66 (1) 54-59
    CrossrefPubMedGoogle Scholar
  • 62 Waubant E, Chabas D, Okuda DT , et al. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol 2009; 66 (8) 967-971
    PubMedGoogle Scholar
  • 63 Danesh-Meyer HV, Papchenko T, Savino PJ, Law A, Evans J, Gamble GD. In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis Sci 2008; 49 (5) 1879-1885
    CrossrefPubMedGoogle Scholar
  • 64 Dalla Via P, Opocher E, Pinello ML , et al. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro-oncol 2007; 9 (4) 430-437
    PubMedGoogle Scholar
  • 65 Fisher MJ, Loguidice M, Gutmann DH , et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-oncol 2012; 14 (6) 790-797
    PubMedGoogle Scholar
  • 66 Avery RA, Liu GT, Fisher MJ , et al. Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol 2011; 151 (3) 542-549
    CrossrefPubMedGoogle Scholar
  • 67 Avery RA, Bouffet E, Packer RJ, Reginald A. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas. Invest Ophthalmol Vis Sci 2013; 54 (2) 1034-1038
    CrossrefPubMedGoogle Scholar
  • 68 Lux AL, Edwards SW, Hancock E , et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004; 364 (9447) 1773-1778
    CrossrefPubMedGoogle Scholar
  • 69 Plant GT, Sergott RC. Understanding and interpreting vision safety issues with vigabatrin therapy. Acta Neurol Scand Suppl 2011; (192) 57-71
    PubMedGoogle Scholar
  • 70 Sergott RC. Recommendations for visual evaluations of patients treated with vigabatrin. Curr Opin Ophthalmol 2010; 21 (6) 442-446
    CrossrefPubMedGoogle Scholar
  • 71 Miller NR, Johnson MA, Paul SR , et al. Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings. Neurology 1999; 53 (9) 2082-2087
    CrossrefPubMedGoogle Scholar
  • 72 Wild JM, Robson CR, Jones AL, Cunliffe IA, Smith PE. Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 2006; 47 (3) 917-924
    CrossrefPubMedGoogle Scholar
  • 73 Lawthom C, Smith PE, Wild JM. Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity. Ophthalmology 2009; 116 (3) 565-571
    CrossrefPubMedGoogle Scholar
  • 74 Clayton LM, Devile M, Punte T , et al. Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals. Ophthalmology 2012; 119 (10) 2152-2160
    CrossrefPubMedGoogle Scholar
  • 75 Clayton LM, Dévilé M, Punte T , et al. Retinal nerve fiber layer thickness in vigabatrin-exposed patients. Ann Neurol 2011; 69 (5) 845-854
    CrossrefPubMedGoogle Scholar
  • 76 Cronin TH, Hertle RW, Ishikawa H, Schuman JS. Spectral domain optical coherence tomography for detection of foveal morphology in patients with nystagmus. J AAPOS 2009; 13 (6) 563-566
    CrossrefPubMedGoogle Scholar
  • 77 Thomas MG, Kumar A, Thompson JR, Proudlock FA, Straatman K, Gottlob I. Is high-resolution spectral domain optical coherence tomography reliable in nystagmus?. Br J Ophthalmol 2013; 97 (4) 534-536
    PubMedGoogle Scholar
  • 78 Thomas MG, Kumar A, Mohammad S , et al. Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity?. Ophthalmology 2011; 118 (8) 1653-1660
    CrossrefPubMedGoogle Scholar
  • 79 Thomas MG, Kumar A, Kohl S, Proudlock FA, Gottlob I. High-resolution in vivo imaging in achromatopsia. Ophthalmology 2011; 118 (5) 882-887
    CrossrefPubMedGoogle Scholar
  • 80 Papageorgiou E, McLean RJ, Gottlob I. Nystagmus in childhood. Pediatr Neonatol 2014; 55 (5) 341-351
    CrossrefPubMedGoogle Scholar
  • 81 Thomas S, Thomas MG, Andrews C , et al. Autosomal-dominant nystagmus, foveal hypoplasia and presenile cataract associated with a novel PAX6 mutation. Eur J Hum Genet 2014; 22 (3) 344-349
    CrossrefPubMedGoogle Scholar
  • 82 Grainger BT, Papchenko TL, Danesh-Meyer HV. Optic nerve atrophy in adrenoleukodystrophy detectable by optic coherence tomography. J Clin Neurosci 2010; 17 (1) 122-124
    CrossrefPubMedGoogle Scholar
  • 83 Aquino JJ, Sotirchos ES, Saidha S, Raymond GV, Calabresi PA. Optical coherence tomography in x-linked adrenoleukodystrophy. Pediatr Neurol 2013; 49 (3) 182-184
    CrossrefPubMedGoogle Scholar
  • 84 Noval S, Contreras I, Sanz-Gallego I, Manrique RK, Arpa J. Ophthalmic features of Friedreich ataxia. Eye (Lond) 2012; 26 (2) 315-320
    CrossrefPubMedGoogle Scholar
  • 85 Seyer LA, Galetta K, Wilson J , et al. Analysis of the visual system in Friedreich ataxia. J Neurol 2013; 260 (9) 2362-2369
    CrossrefPubMedGoogle Scholar
  • 86 Rosenberg R, Halimi E, Mention-Mulliez K, Cuisset JM, Holder M, Defoort-Dhellemmes S. Five year follow-up of two sisters with type II sialidosis: systemic and ophthalmic findings including OCT analysis. J Pediatr Ophthalmol Strabismus 2013; 50 Online: e33-e36
    PubMedGoogle Scholar
  • 87 Rudich DS, Curcio CA, Wasserstein M, Brodie SE. Inner macular hyperreflectivity demonstrated by optical coherence tomography in niemann-pick disease. JAMA Ophthalmol 2013; 131 (9) 1244-1246
    CrossrefPubMedGoogle Scholar
  • 88 Orlin A, Sondhi D, Witmer MT , et al. Spectrum of ocular manifestations in CLN2-associated batten (Jansky-Bielschowsky) disease correlate with advancing age and deteriorating neurological function. PLoS ONE 2013; 8 (8) e73128
    CrossrefPubMedGoogle Scholar